Search research articles
Contact Us
Filters
Showing results (121-130 of 126) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 126 results.
The Journal of Clinical Endocrinology and Metabolism
|
November 30, 2000
The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults
A M Rosenfalck, S Maghsoudi, S Fisker, et al.
Diabetologia
|
June 1, 1995
Intranasal insulin therapy: the clinical realities
J Hilsted, S Madsbad, A Hvidberg, et al.
Pharmacology & Toxicology
|
September 1, 1996
Bioavailability of recombinant human growth hormone in different concentrations and formulations
N Vahl, S B Jensen, M H Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2001
Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment
S Fisker, K Kristensen, A M Rosenfalck, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
April 25, 2001
Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance
D Hansen, A Astrup, S Toubro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group
A F Attanasio, S W Lamberts, A M Matranga, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 126) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 126 results.
The Journal of Clinical Endocrinology and Metabolism
|
November 30, 2000
The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults
A M Rosenfalck, S Maghsoudi, S Fisker, et al.
Diabetologia
|
June 1, 1995
Intranasal insulin therapy: the clinical realities
J Hilsted, S Madsbad, A Hvidberg, et al.
Pharmacology & Toxicology
|
September 1, 1996
Bioavailability of recombinant human growth hormone in different concentrations and formulations
N Vahl, S B Jensen, M H Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2001
Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment
S Fisker, K Kristensen, A M Rosenfalck, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
April 25, 2001
Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance
D Hansen, A Astrup, S Toubro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group
A F Attanasio, S W Lamberts, A M Matranga, et al.
Page
of 13